American journal of surgery · 1981
Prospective controlled trial of cryoprecipitated plasma, plasma protein fraction and serum albumin solution for kidney preservation.
Клиническое исследованиеСравнительное исследованиеКонтролируемое клиническое исследованиеСтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Cho S I, Bradley J W, Garovoy M R, Nabseth D C
Аннотация
A controlled prospective study was conducted to compare the results of kidney preservation and transplantation in regard to the type of perfusate used for perfusion preservation. Cryoprecipitated plasma, plasma protein fraction and serum albumin solution were used as perfusate. Between February 1979 and July 1980, 176 kidneys were preserved by one of these perfusates and transplanted. There was no statistically significant difference in the donor and recipient status, perfusion characteristics or graft and patient survival among the three groups. Synthetic perfusates are an acceptable alternative to cryoprecipitated plasma for perfusion preservation of cadaver kidneys.
Предметные рубрики MeSH
AdultBlood ProteinsCadaverClinical Trials as TopicCryoprotective AgentsEvaluation Studies as TopicFollow-Up StudiesGraft SurvivalHumansKidney TransplantationOrgan PreservationPerfusionPlasma SubstitutesPreservatives, PharmaceuticalProspective StudiesSerum AlbuminSerum Albumin, HumanSerum GlobulinsSolutionsTissue PreservationTransplantation, Homologous